2026 AAD Annual Meeting: Once Daily Pill to Treat Rare Skin and Muscle Disease Gets Rapid Review by FDA

HealthDay speaks with Ruth Ann Vleugels, MD, MPH, MBA, Mass General Brigham Dermatology, Harvard Medical School, AAD Board Member, about her landmark study on a new oral treatment for dermatomyositis